View Press Releases
-
X4 Pharmaceuticals Appoints Derek Meisner, J.D., as General Counsel
CAMBRIDGE, MA, UNITED STATES - Nov 4, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the appointment of Derek Meisner, J
Nov 4, 2019
-
Shimmer Receives CE Certification for its ECGmd Holter Monitor Electrocardiograph
CAMBRIDGE, MA - Nov 4, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that ECGmd – its five-wire, four-lead holter monitor electrocardiograph (ECG) – is now a CE certified, Class IIa medical device under the Medical Device Directive (93/42/EEC)
Nov 4, 2019
-
Watson-Marlow Fluid Technology Group’s puresu single-use tube assemblies offer reliable, sterile, customisable solutions for bioprocessing
FALMOUTH, UK - Oct 31, 2019 - Watson-Marlow Fluid Technology Group (WMFTG) announces the expansion of its puresu® single-use range, providing a combination of components that are safe and easy-to-install
Oct 31, 2019
-
Creative BioMart Enhanced Its Protein Kinase Assay Service for Protein Research
SHIRLEY, NY, UNITED STATES - Oct 31, 2019 - Creative BioMart, a global specialized CRO providing high quality protein analytical services to support research, manufacturing and clinical development of native and recombinant proteins, is glad to enhance its protein kinase assay service recently to help customers accelerate their discovery and to help explore new frontiers in biological science
Oct 30, 2019
-
Moving the Conversation from Cost to Value: VeraSci Offers New Approach to HEOR and HTA Consulting Led by Dr. Luca Pani
DURHAM, NC, UNITED STATES - Oct 28, 2019 - VeraSci, a leading provider of innovative scientific and technology services, announces the addition of a new service offering, Value Consulting, a HEOR and HTA consulting service line, addressing the emerging need to demonstrate the pharmacoeconomic value of novel therapies earlier in the development process
Oct 30, 2019
-
Winners of the 2019 President’s Startup Challenge Announced, as The Pistoia Alliance Looks to the Future
BOSTON, MA, UNITED STATES - Oct 30, 2019 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, has announced the winners of the 2019 Presidents Startup Challenge at its annual member conference in Boston
Oct 30, 2019
-
Iceni Diagnostics appoints Chris Liggett to accelerate route-to-market strategy
NORWICH, UNITED KINGDOM - Oct 31, 2019 - As Iceni Diagnostics, developer of glycoscience-based diagnostics, therapies and vaccines, moves closer to market it has appointed Chris Liggett, business strategist and new product development specialist, to support its commercial operations
Oct 30, 2019
-
Optibrium Announce the Release of StarDrop™ 6.6
CAMBRIDGE, UNITED KINGDOM - Oct 30, 2019 - Optibrium, a developer of software for drug discovery, today announced the introduction of StarDrop 6
Oct 30, 2019
-
Compound Screening Platform Is Launched by BOC Sciences for Drug Discovery Research
SHIRLEY, NY, NY, UNITED STATES - Oct 30, 2019 - With unceasing steps in the field of drug discovery, BOC Sciences, primarily known as an industry-leading chemical vendor, recently launches an efficient, economical and systematic one-stop compound screening platform, in a hope to fulfill the clients demand in drug R&D
Oct 29, 2019
-
Diagnostics Industry Veteran Dr. Frédéric Sweeney Joins MeMed as Chief Business Development Officer
HAIFA, ISRAEL - Oct 29, 2019 - MeMed Ltd., a leader in host response-based diagnostic solutions, today announced the addition of Dr
Oct 29, 2019
-
Alfa Chemistry Launched Microalgae Powder Services
NEW YORK, NY, UNITED STATES - Oct 29, 2019 - On October 24, 2019, Alfa Chemistry announced that it has launched microalgae powder production services
Oct 29, 2019
-
Sterling Pharma Solutions invests $1.5m into US facility expansion
NORTH CAROLINA, N/A - Oct 28, 2019 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing $1
Oct 28, 2019
-
ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies
SCHILTHIGHEIM, FRANCE - Oct 28, 2019 - For researchers looking to accelerate the development of new immunotechnologies, ProteoGenix has created 2 new naïve rabbit and human antibody phage display libraries
Oct 28, 2019
-
A prediction of gene sequencing application areas and scale by CD Genomics
SHIRLEY, NY, UNITED STATES - Oct 28, 2019 - The upstream of the gene sequencing industry is the supply of sequencing instruments, sequencing reagents and consumables
Oct 27, 2019
-
BOC Sciences Upgrades Bioconjugation Service to Help Advance Targeted Drug Delivery Research
SHIRLEY, NY, UNITED STATES - Oct 22, 2019 - Targeted drug delivery is by no means easy task, but luckily bioconjugation can be of great assistance
Oct 27, 2019
-
Creative Proteomics Provides Glycosylation Service for Lab Research
SHIRLEY, NY - Oct 25, 2019 - Since its establishment in 2004, Creative Proteomics has gradually been a leading supplier providing proteomics, glycomics, metabolomics and bioinformatics analysis services
Oct 24, 2019
-
Spring Bank Announces Interim Top-Line Results from the First Cohort of the Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy® in Chronic Hepatitis B Patients
HOPKINTON, MA, UNITED STATES - Oct 17, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced interim top-line results at 12 weeks from the first cohort of the ongoing Phase 2 trial evaluating the safety, efficacy and pharmacodynamics of escalating doses (50mg, 200mg and 400mg) of the investigational compound inarigivir co-administered with Gilead Sciences Vemlidy® (tenofovir alafenamide 25mg) for the treatment of chronic hepatitis B virus (HBV) infection
Oct 24, 2019
-
KCR Announces new Chief Technology Officer
BOSTON, MA, US - Oct 24, 2019 - KCR, an international clinical development solutions provider, has named Douglas Bain the organizations Chief Technology Officer
Oct 24, 2019
-
TrialScope Acquires Clinical Trial Connect
JERSEY CITY, NJ, US - Oct 24, 2019 - TrialScope, the global leader in transparency and disclosure compliance solutions, has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials
Oct 24, 2019
-
MR Solutions’ new preclinical imaging PET/CT range on display at EANM ‘19
GUILDFORD, UNITED KINGDOM - Oct 24, 2019 - MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM 19, (European Association of Nuclear Medicine) last week in Barcelona
Oct 24, 2019